|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
11
|
|
pubmed:dateCreated |
1999-3-5
|
|
pubmed:abstractText |
The purpose of this study was to assess the role of transforming growth factor (TGF)-beta1 in the development of diabetes-associated mesenteric vascular hypertrophy and in the antitrophic effect of angiotensin converting enzyme inhibitors.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0263-6352
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1603-9
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9856360-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:9856360-Animals,
pubmed-meshheading:9856360-Blood Glucose,
pubmed-meshheading:9856360-Blood Pressure,
pubmed-meshheading:9856360-Blotting, Northern,
pubmed-meshheading:9856360-Body Weight,
pubmed-meshheading:9856360-Collagen,
pubmed-meshheading:9856360-Diabetes Mellitus, Experimental,
pubmed-meshheading:9856360-Diabetic Angiopathies,
pubmed-meshheading:9856360-Gene Expression,
pubmed-meshheading:9856360-Immunohistochemistry,
pubmed-meshheading:9856360-Male,
pubmed-meshheading:9856360-RNA, Messenger,
pubmed-meshheading:9856360-Ramipril,
pubmed-meshheading:9856360-Rats,
pubmed-meshheading:9856360-Rats, Sprague-Dawley,
pubmed-meshheading:9856360-Transforming Growth Factor beta,
pubmed-meshheading:9856360-Vascular Diseases
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Angiotensin converting enzyme inhibition reduces the expression of transforming growth factor-beta1 and type IV collagen in diabetic vasculopathy.
|
|
pubmed:affiliation |
Department of Medicine, University of Melbourne, Austin & Repatriation Medical Centre, Heidelberg, Australia.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
